Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor
- 5 January 2004
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (1), 251-256
- https://doi.org/10.1016/j.bmcl.2003.09.074
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variantsBioorganic & Medicinal Chemistry Letters, 2003
- Emerging therapies for hepatitis C virus infectionEmerging Drugs, 2001
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and CirrhosisThe New England Journal of Medicine, 2000
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CThe New England Journal of Medicine, 2000
- Novel Approaches to the Treatment of Hepatitis C Virus InfectionAntiviral Chemistry and Chemotherapy, 2000
- The Design and Synthesis of Potent Inhibitors of Hepatitis C Virus NS3–4A ProteinaseAntiviral Chemistry and Chemotherapy, 1999
- Hepatitis C virus NS3/4A proteaseAntiviral Research, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CThe New England Journal of Medicine, 1998
- Molecular virology of hepatitis C virus.Journal of General Virology, 1997
- Molecular Targets in Inhibition of Hepatitis C Virus ReplicationAntiviral Chemistry and Chemotherapy, 1997